Improving Access to Advanced Nonsteroidal Topical Therapies in Inflammatory Dermatoses

In the final episode, “Improving Access to Advanced Nonsteroidal Topical Therapies in Inflammatory Dermatoses,” the panelists explored practical strategies for overcoming barriers to advanced nonsteroidal topical therapies and discussed how these treatments are reshaping long-term disease management. Building on the consensus statement addressing affordable access, the expert faculty examine the challenges patients and clinicians face when attempting to obtain newer targeted topical treatments and review resources that may help improve treatment accessibility.

Throughout the discussion, the panel highlights the role of dermatology-focused specialty pharmacies in helping patients navigate insurance restrictions, formulary limitations, prior authorization requirements, and affordability concerns. Faculty members discuss how dedicated pharmacy support services, manufacturer assistance programs, and patient support resources can increase the likelihood that patients successfully obtain and maintain treatment with advanced topical therapies. The conversation also addresses common misconceptions regarding access and the perception that prescribing newer therapies inevitably creates excessive administrative burden.

The panel reflects on how improved access to advanced nonsteroidal topicals supports broader treatment goals, including reducing cumulative corticosteroid exposure and promoting long-term disease control. Faculty members emphasize that these therapies should not be viewed as replacements for topical corticosteroids, but rather as complementary tools that help clinicians practice more effective corticosteroid stewardship. The discussion reinforces the importance of integrating new scientific advances into clinical practice while balancing efficacy, safety, tolerability, and accessibility.

As the series concludes, the expert faculty summarize the key themes of the consensus paper, highlighting the need to move beyond reactive treatment approaches and embrace strategies that support safe, effective, and sustainable management of inflammatory dermatoses. Thank you for watching this between the lines series on inflammatory dermatoses. Please subscribe to our newsletter for information on upcoming video series.